Suppr超能文献

多囊卵巢综合征患者接受减重手术以自发排卵:BAMBINI 多中心、开放标签、随机对照试验。

Bariatric surgery for spontaneous ovulation in women living with polycystic ovary syndrome: the BAMBINI multicentre, open-label, randomised controlled trial.

机构信息

Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK; Department of Diabetes & Endocrinology, Imperial College Healthcare NHS Trust, London, UK.

Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK; Warwick Medical School, University of Warwick, Warwick, UK.

出版信息

Lancet. 2024 Jun 8;403(10443):2489-2503. doi: 10.1016/S0140-6736(24)00538-5. Epub 2024 May 20.

Abstract

BACKGROUND

Polycystic ovary syndrome (PCOS) is the most common cause of anovulatory infertility. Obesity exacerbates the reproductive complications of PCOS; however, the management of obesity in women with PCOS remains a large unmet clinical need. Observational studies have indicated that bariatric surgery could improve the rates of ovulatory cycles and prospects of fertility; however, the efficacy of surgery on ovulation rates has not yet been compared with behavioural modifications and medical therapy in a randomised trial. The aim of this study was to compare the safety and efficacy of bariatric surgery versus medical care on ovulation rates in women with PCOS, obesity, and oligomenorrhoea or amenorrhoea.

METHODS

In this multicentre, open-label, randomised controlled trial, 80 women older than 18 years, with a diagnosis of PCOS based on the 2018 international evidence-based guidelines for assessing and managing PCOS, and a BMI of 35 kg/m or higher, were recruited from two specialist obesity management centres and via social media. Participants were randomly assigned at a 1:1 ratio to either vertical sleeve gastrectomy or behavioural interventions and medical therapy using a computer-generated random sequence (PLAN procedure in SAS) by an independent researcher not involved with any other aspect of the clinical trial. The median age of the entire cohort was 31 years and 79% of participants were White. The primary outcome was the number of biochemically confirmed ovulatory events over 52 weeks, and was assessed using weekly serum progesterone measurements. The primary endpoint included the intention-to-treat population and safety analyses were per-protocol population. This study is registered with the ISRCTN registry (ISRCTN16668711).

FINDINGS

Participants were recruited from Feb 20, 2020 to Feb 1, 2021. 40 participants were assigned to each group and there were seven dropouts in the medical group and ten dropouts in the surgical group. The median number of ovulations was 6 (IQR 3·5-10·0) in the surgical group and 2 (0·0-4·0) in the medical group. Women in the surgical group had 2.5 times more spontaneous ovulations compared with the medical group (incidence rate ratio 2·5 [95% CI 1·5-4·2], p<0·0007). There were more complications in the surgical group than the medical group, although without long-term sequelae. There were 24 (66·7%) adverse events in the surgical group and 12 (30·0%) in the medical group. There were no treatment-related deaths.

INTERPRETATION

Bariatric surgery was more effective than medical care for the induction of spontaneous ovulation in women with PCOS, obesity, and oligomenorrhoea or amenorrhoea. Bariatric surgery could, therefore, enhance the prospects of spontaneous fertility in this group of women.

FUNDING

The Jon Moulton Charity Trust.

摘要

背景

多囊卵巢综合征(PCOS)是无排卵性不孕的最常见原因。肥胖会使 PCOS 的生殖并发症恶化;然而,PCOS 患者的肥胖管理仍然是一个巨大的未满足的临床需求。观察性研究表明,减肥手术可以提高排卵周期和生育的可能性;然而,手术对排卵率的疗效尚未在随机试验中与行为改变和药物治疗进行比较。本研究旨在比较减肥手术与医疗护理对患有 PCOS、肥胖症和月经稀少或闭经的女性排卵率的安全性和疗效。

方法

在这项多中心、开放标签、随机对照试验中,从两个专门的肥胖症管理中心和社交媒体招募了 80 名年龄在 18 岁以上的女性,她们根据 2018 年国际评估和管理 PCOS 的循证指南诊断为 PCOS,且 BMI 为 35kg/m2 或更高。参与者按照 1:1 的比例随机分配至垂直袖状胃切除术或行为干预和药物治疗组,使用计算机生成的随机序列(SAS 中的 PLAN 程序)由不参与临床试验其他方面的独立研究人员进行。整个队列的中位年龄为 31 岁,79%的参与者为白人。主要结局是 52 周内生化确认的排卵事件数,通过每周血清孕激素测量进行评估。主要终点包括意向治疗人群和安全性分析为方案人群。该研究在 ISRCTN 注册处(ISRCTN65414363)注册。

结果

参与者于 2020 年 2 月 20 日至 2021 年 2 月 1 日招募。每组分配 40 名参与者,药物治疗组有 7 名脱落,手术组有 10 名脱落。手术组的排卵中位数为 6(IQR 3.5-10.0),药物治疗组为 2(0.0-4.0)。与药物治疗组相比,手术组的自发性排卵次数多 2.5 倍(发生率比 2.5 [95%CI 1.5-4.2],p<0.0007)。手术组的并发症多于药物治疗组,但没有长期后遗症。手术组有 24 名(66.7%)出现不良事件,药物治疗组有 12 名(30.0%)。没有与治疗相关的死亡。

解释

减肥手术在诱导患有 PCOS、肥胖症和月经稀少或闭经的女性自发性排卵方面比药物治疗更有效。因此,减肥手术可以提高这群女性的自然生育能力。

资金

Jon Moulton 慈善信托基金。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验